uniQure NV Stock Price - QURE

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
After Hours
Last Trade
Last $ 67.53 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
uniQure NV QURE NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.88 1.32% 67.53 68.2699 66.3886 66.65 66.65 20:00:00
Bid Price Ask Price Spread Spread % News
61.55 74.00 12.45 16.82% 1 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
7,236 588,296 $ 67.49 $ 39,703,011 636,102 30.2367 - 82.49
Last Trade Time Type Quantity Stock Price Currency
17:45:43 priorref 1,664 $ 67.53 USD

uniQure NV Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 2.95B 43.62M $ -83.30M -2.34 - 42.51M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

uniQure NV News

Loading Messages....

Latest QURE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QURE Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week74.2276.686964.048568.60876,546-6.69-9.01%
1 Month70.4876.686964.048570.64531,180-2.95-4.19%
3 Months46.2276.686945.8263.53551,39521.3146.11%
6 Months69.8876.8536.2056.38558,016-2.35-3.36%
1 Year31.0082.4930.236759.50591,45136.53117.84%
3 Years5.9482.494.7239.38426,30261.591,036.87%
5 Years20.1082.494.7232.46375,65947.43235.97%

uniQure NV Description

uniQure NV is a gene therapy company. It develops treatment and platform for patients suffering from genetic and other devastating diseases. Its products and services are focused towards hemophilia, Huntington's disease, and cardiovascular diseases. The company's manufacturing facility is located in Lexington Massachusetts and research and development facility in Amsterdam, the Netherlands, and Heidelberg, Germany. It is focused on the development of pipeline of gene therapies with the collaboration of Bristol Myers-Squibb for cardiovascular diseases.

Your Recent History
uniQure NV
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.